Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease

By Cacciatore Ivana   Marinelli Lisa   Fornasari Erika   Cerasa Laura S.   Eusepi Piera   Türkez Hasan   Pomilio Cristina   Reale Marcella   D’Angelo Chiara   Costantini Erica   Di Stefano Antonio  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1035-1035

MDPI

Access to resources Recommend Favorite

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

By Moore Amy H.   Bigbee Matthew J.   Boynton Grace E.   Wakeham Colin M.   Rosenheim Hilary M.   Staral Christopher J.   Morrissey James L.   Hund Amanda K.  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1812-1841

MDPI

Access to resources Recommend Favorite

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease

By Calkins Marcus J.   Manczak Maria   Reddy P. Hemachandra  

Pharmaceuticals, Vol. 5, Iss. 10, 2012-10 ,pp. : 1103-1119

MDPI

Access to resources Recommend Favorite

Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease

By Aliev Gjumrakch   Palacios Hector H.   Gasimov Eldar   Obrenovich Mark E.   Morales Ludis   Leszek Jerzy   Bragin Valentin   Herrera Arturo Solís   Gokhman Dmitry  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 158-187

MDPI

Access to resources Recommend Favorite

Unlocking the Door to Neuronal Woes in Alzheimer’s Disease: Aβ and Mitochondrial Permeability Transition Pore

By Du Heng   Yan Shirley ShiDu  

Pharmaceuticals, Vol. 3, Iss. 6, 2010-06 ,pp. : 1936-1948

MDPI

Access to resources Recommend Favorite